Atopic Dermatitis clinical trial of arise
Recruiting patients for Phase 2 trials of a novel injectable treatment for Atopic Dermatitis (Eczema)
Volunteer Requirements
Moderate or severe atopic dermatitis affecting at least 10% of skin surface for at least 10 months
A history of inadequate response to topical medications
Between 18 and 65 years of age
Trial Overview
Arise is a new injectable biologic currently in clinical trials for eczema. It targets the immune system response that causes symptoms and has the potential to be much more effective than topicals or creams.
Length of Study
The study lasts 24 weeks and requires 12 visits to the clinic in Barrie, Ontario.
Travel and time expenses are covered.
Other Clinical Trials
As part of managing your time with us, we may collect cookies, IP addresses, and other data you submit. We protect user data by using both data regulation and cyber security protocols. We will never sell your information to anyone. We use your internet data to effectively communicate, and any submitted personal data to register you for our trials.
Simcoderm Clinical Trials has a ten year history that has brought us to the cutting edge of clinical research. Many of our trials have been the first of their kind in Canada and at times in the world.
We’ve run over seventy five clinical trials, and more than fifteen for Atopic Dermatitis.
Our office is located in Barrie, Ontario.